Showing results (191-200 of 203) with videos related to

Sort By:
Pageof 21
Translational Stroke Research|January 6, 2022
Genome-Wide Association Study of Clinical Outcome After Aneurysmal Subarachnoid Haemorrhage: ProtocolBen Gaastra, Sheila Alexander, Mark K Bakker, et al.
Translational Stroke Research|October 20, 2022
A Genome-Wide Association Study of Outcome After Aneurysmal Subarachnoid Haemorrhage: Discovery AnalysisBen Gaastra, Sheila Alexander, Mark K Bakker, et al.
Brain : a Journal of Neurology|October 8, 2021
The impact of smoking cessation on multiple sclerosis disease progressionJeff Rodgers, Tim Friede, Frederick W Vonberg, et al.
The Lancet. Psychiatry|June 29, 2020
Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance studyAravinthan Varatharaj, Naomi Thomas, Mark A Ellul, et al.
The Lancet. Neurology|September 19, 2020
Potential human transmission of amyloid β pathology: surveillance and risksElsa Lauwers, Giovanna Lalli, Sebastian Brandner, et al.
The Lancet. Neurology|March 21, 2015
Neuroinflammation in Alzheimer's diseaseMichael T Heneka, Monica J Carson, Joseph El Khoury, et al.
European Journal of Neurology|April 3, 2024
Real-world persistence of multiple sclerosis disease-modifying therapiesEmma C Tallantyre, Ruth Dobson, Joseph L J Froud, et al.
The Lancet. Child & Adolescent Health|July 17, 2021
Neurological manifestations of SARS-CoV-2 infection in hospitalised children and adolescents in the UK: a prospective national cohort studyStephen T J Ray, Omar Abdel-Mannan, Mario Sa, et al.
Brain Communications|August 19, 2021
Spectrum, risk factors and outcomes of neurological and psychiatric complications of COVID-19: a UK-wide cross-sectional surveillance studyAmy L Ross Russell, Marc Hardwick, Athavan Jeyanantham, et al.
Lancet (London, England)|October 4, 2025
Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trialJeremy Chataway, Thomas Williams, James Blackstone, et al.
Pageof 21